Key result
Vagal nerve stimulation improves 140-day survival to 86% vs 50% for sham in rat HF.
Why the study?
Diminished cardiac vagal activity and higher heart rate predict high mortality in chronic heart failure after myocardial infarction, but effects of chronic vagal nerve stimulation on cardiac remodeling and survival were unclear.
Does chronic electrical stimulation of the vagus nerve improve survival in rats with chronic heart failure after myocardial infarction?
RCT
randomized
Does chronic electrical stimulation of the vagus nerve improve survival in rats with chronic heart failure after myocardial infarction?
In a rat model of chronic heart failure post-myocardial infarction, chronic vagal nerve stimulation significantly improved hemodynamics, reduced cardiac remodeling, and markedly increased long-term survival.
Hypothesis-generating for vagal stimulation in post-MI heart failure; human trials needed before clinical adoption.
BACKGROUND: Diminished cardiac vagal activity and higher heart rate predict a high mortality rate of chronic heart failure (CHF) after myocardial infarction. We investigated the effects of chronic electrical stimulation of the vagus nerve on cardiac remodeling and long-term survival in an animal model of CHF after large myocardial infarction. METHODS AND RESULTS: Two weeks after the ligation of the left coronary artery, surviving rats were randomized to vagal- and sham-stimulated groups. Using an implantable miniature radio-controlled electrical stimulator, we stimulated the right vagal nerve of CHF rats for 6 weeks. The intensity of electrical stimulation was adjusted for each rat, so that the heart rate was lowered by 20 to 30 beats per minute. The treated rats had significantly lower left ventricular end-diastolic pressure (17.1+/-5.9 versus 23.5+/-4.2 mm Hg, P<0.05) and higher maximum dp/dt of left ventricular pressure (4152+/-237 versus 2987+/-192 mm Hg/s, P<0.05) than the untreated rats. Improvement of cardiac pumping function was accompanied by a decrease in normalized biventricular weight (2.75+/-0.25 versus 3.14+/-0.22 g/kg, P<0.01). Although the 140-day survival of the untreated group was only half, vagal stimulation markedly improved the survival rate (86% versus 50%, P=0.008). Vagal stimulation therapy achieved a 73% reduction in a relative risk ratio of death. CONCLUSIONS: Vagal nerve stimulation markedly improved the long-term survival of CHF rats through the prevention of pumping failure and cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Li et al. (2003) conducted an RCT in Chronic heart failure after myocardial infarction. Vagal nerve stimulation vs. Sham stimulation was evaluated on 140-day survival (73% reduction in relative risk ratio, p=0.008). Vagal nerve stimulation markedly improved 140-day survival compared to sham stimulation in rats with chronic heart failure (86% vs 50%, P=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: